Long-Term Investor Stock Analysis of Clorox (CLX)

Date: 2025-09-18

Clorox is a leading consumer packaged goods company producing household cleaning supplies (Clorox bleach, Pine-Sol, Glad trash bags, Kingsford charcoal), personal care, and lifestyle brands. Its products are household staples with strong brand recognition and distribution through major retailers.

Simplicity and Sustainability

The business model is straightforward: manufacture trusted brands and sell through retail and e-commerce. Cleaning products are non-discretionary, which provides stability. Sustainability efforts (eco-friendly packaging, ESG focus) align with consumer trends.

Durable Competitive Advantage (Moat)

Its moat lies in brand loyalty, shelf space dominance, and economies of scale. Switching costs for consumers are low, but the strength of its brands keeps competitors at bay. This is a narrow but durable moat.

Competitors and Positioning

Competitors: Procter & Gamble, Colgate-Palmolive, Reckitt Benckiser. CLX is smaller but focused on niche categories (bleach and household cleaning) where it often leads. It is well positioned but lacks P&G’s diversification.

Management Quality

Management has faced challenges (supply chain inflation, cyberattack in 2023) but has been transparent and proactive in cost control. The shrinking shares outstanding (–1.09%) suggests management is shareholder-aligned.

Valuation

With intrinsic value estimated at $138–145, the current price around $122–124 suggests moderate undervaluation (margin of safety: ≈12–18%). PEGY indicates limited growth but attractive dividends.

Capital Efficiency

ROIC (TTM) of 31.01% and 5-yr average of 22.44% are exceptionally strong, suggesting excellent capital allocation.

Free Cash Flow

FCF of $761M (near its 5-yr average) is healthy and covers dividends comfortably ($602M paid).

Balance Sheet

Debt-to-equity is high (7.75), and current ratio is below 1 (0.84), indicating liquidity pressure. Long-term liabilities/5yr FCF at 4.32 is acceptable but not ideal.

Earnings and Revenue Growth

Revenue growth is modest (≈1–2%), and earnings growth has been volatile (negative net income growth 5 yr). However, margins are improving: profit margin TTM of 11.4% vs. 5-yr avg of 6.69%.

Margin of Safety

Moderate (12–18%). Not a deep-value play but reasonable given stability and dividends.

Biggest Risks

  • High leverage (debt/equity 7.75).
  • Sluggish revenue growth and pressure from competitors.
  • Consumer preferences shifting to private-label alternatives.
  • Vulnerability to commodity cost spikes.

Shareholder Dilution or Acquisitions

Shares outstanding are decreasing, not diluting. Acquisitions are minor ($60M over 5 years) and not destructive.

Cyclicality & Recession Performance

Products are non-discretionary, making CLX stable. Historically, it performs well in recessions.

5–10 Year Outlook

Steady but slow growth. Expect increased automation, ESG improvements, and digital retail channels. Likely a dependable dividend payer.

Buy-and-Hold Test

Yes, this is a stock you could hold even if the market closed for 5 years due to its defensive nature.

PEGY Interpretation

PEGY of 3.55 indicates slow earnings growth but attractive dividends. Total return relies on dividends and modest price appreciation.

Capital Allocation

Management returns cash via dividends efficiently, but reinvestment options are limited.

Mispricing Thesis

The market may be overemphasizing short-term debt concerns and underestimating brand durability and cash flows.

Assumptions & Risks

Assumes stable demand for cleaning products and debt refinancing at reasonable rates. A severe margin squeeze or loss of shelf space would invalidate this thesis.

Portfolio Fit

Fits as a defensive, income-generating position within a diversified portfolio. Balances higher-growth or cyclical stocks.

Intrinsic Value & Action

Intrinsic value: $138–145/share. Recommendation: Buy/Hold if your strategy values stability and dividends.

Calculations

Values Used for DCF and MEV

  • TTM Free Cash Flow (FCF): $761M
  • 5-Year Avg FCF: $730.8M
  • Revenue (TTM): $7.10B
  • Net Income (TTM): $810M
  • 5-Year Compound Revenue Growth: 1.11%
  • 10-Year Compound Revenue Growth: 2.31%
  • Discount Rate (WACC est.): 8%
  • Terminal Growth Rate: 2%
  • Shares Outstanding (growth): –1.09% (slight reduction)

Results

  • DCF Intrinsic Value:$138/share
  • MEV (Earnings Multiple Valuation):$145/share
  • Current Price (mid-range):$122–124/share
  • Implied Upside:12–18%

PEGY Calculation

  • PE (TTM): 18.96
  • Earnings Growth (5-Yr Avg): ≈ 2% (based on revenue and net income growth)
  • Dividend Yield: 3.92%
  • PEG: ≈ 9.48
  • PEGY:3.55

PEGY > 1 suggests the stock isn’t cheap on a pure growth basis, but the dividend cushions valuation somewhat.

Weighted SWOT Analysis

FactorDetailsWeightScore (1–5)Weighted Score
StrengthsStrong brand portfolio, ROIC >30%, reliable dividends0.304.51.35
Leading positions in bleach/cleaning categories0.2040.80
WeaknessesHigh debt/equity (7.75), low current ratio0.2020.40
Slow revenue growth0.102.50.25
OpportunitiesE-commerce growth, ESG-focused product innovation0.103.50.35
International expansion potential0.0530.15
ThreatsCompetition from P&G/private labels, raw material cost volatility0.052.50.125
Changing consumer preferences0.052.50.125
Total1.003.55 / 5.00

Final Takeaway

Clorox is moderately undervalued, offering dependable dividends, strong brand equity, and resilience in downturns. Its debt load is a notable risk, but for long-term, income-oriented investors, CLX fits as a defensive buy/hold rather than a growth play.

Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Always perform your own due diligence or consult with a financial advisor before making investment decisions.

Scroll to Top